Lixi Li Selected Research

Lixi Li Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2017
15	Neoplasms (Cancer) 03/2023 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2023
2	Adenoid Cystic Carcinoma (Cylindroma) 12/2022 - 07/2022
2	Lymphatic Metastasis 07/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 07/2022 - 02/2020
2	Cardiotoxicity 06/2022 - 12/2018
2	Fibrosis (Cirrhosis) 01/2021 - 11/2020
2	Triple Negative Breast Neoplasms 01/2021 - 12/2018
2	Alzheimer Disease (Alzheimer's Disease) 05/2013 - 01/2011
2	Memory Disorders (Memory Loss) 05/2013 - 01/2011
1	Diarrhea 11/2023
1	Pathologic Complete Response 11/2023
1	Alcoholic Fatty Liver 02/2023
1	Ductal Carcinoma 01/2023
1	Squamous Cell Carcinoma of Head and Neck 09/2022
1	Adenocarcinoma of Lung 01/2022
1	Ureteral Obstruction 11/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 11/2020
1	Chromosomal Instability (Chromosome Stability) 10/2020
1	Thrombosis (Thrombus) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Peripheral Arterial Disease 11/2016
1	Cognitive Dysfunction 05/2013
1	Hypoxia (Hypoxemia) 03/2013
1	Amyloid Plaque 01/2011

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 03/2023 - 05/2019
5	Hormones (Hormone)IBA 08/2022 - 05/2019
4	Circulating Tumor DNAIBA 08/2022 - 01/2017
3	human ERBB2 proteinIBA 01/2022 - 01/2020
3	Amyloid (Amyloid Fibrils)IBA 05/2013 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 03/2024 - 11/2023
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 09/2022
2	Estrogen ReceptorsIBA 01/2022 - 01/2021
2	Sirolimus (Rapamycin)FDA Link 08/2020 - 05/2013
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
1	Trastuzumab (Herceptin)FDA Link 11/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2023
1	Methionine (L-Methionine)FDA Link 02/2023
1	Choline (Choline Chloride)IBA 02/2023
1	10-methyl spiro(4.5)dec-6-en-6-carboxylic acidIBA 01/2023
1	Lapatinib (GW572016)FDA Link 09/2022
1	Epidermal Growth Factor (EGF)IBA 08/2022
1	AnthracyclinesIBA 06/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Regulatory-Associated Protein of mTORIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	Complement System Proteins (Complement)IBA 12/2021
1	Immunoconjugates (Immunoconjugate)IBA 12/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Vascular Endothelial Growth Factor CIBA 01/2021
1	ChemokinesIBA 11/2020
1	tamibaroteneIBA 11/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	Cell-Free Nucleic AcidsIBA 10/2020
1	Therapeutic UsesIBA 02/2020
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Calcium-Binding ProteinsIBA 01/2020
1	pyrotinibIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Everolimus FDA Link 05/2019
1	TOR Serine-Threonine KinasesIBA 05/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2013
1	LithiumIBA 01/2011
1	Glycogen Synthase (Synthase I)IBA 01/2011

Therapy/Procedure

13	Therapeutics 11/2023 - 01/2017
4	Radiotherapy 01/2023 - 01/2022
4	Adjuvant Chemotherapy 09/2022 - 12/2018
4	Drug Therapy (Chemotherapy) 06/2022 - 12/2018
1	Immunotherapy 01/2022
1	Catheters 01/2020
1	Maintenance Chemotherapy 01/2020
1	Central Venous Catheters 01/2020
1	Renal Dialysis (Hemodialysis) 11/2016